G2
Contact
G2
Contact

Deal analysis · Insurtech

Sofía: USD 21 million round led by Kfund

The digital health insurer for SMEs, licensed as a specialised health insurer and reinsured by RGA, adds USD 21 million and reaches USD 46 million raised since 2018; the licence and renewal above 95% explain the price.

By Israel Cerda de la Garza ( LinkedIn opens in a new window ) · · 5 min read

Sofía, a digital health insurer for SMEs based in Mexico City, announced on 5 May 2026 a USD 21 million round led by Kfund, with Kayyak Ventures joining and Index Ventures, Kaszek and BID Lab participating. It brings the total raised since the company’s founding in 2018 to USD 46 million. It is the largest insurtech round announced in Mexico in the last twelve months among those we track, and the only one for an insurer with its own licence.

The transaction

Kfund, a European fund with more than USD 650 million under management, leads the round; Sofía was its first Mexican investment, in 2024. Kayyak Ventures enters for the first time. Index Ventures has participated since the Series A, Kaszek since the seed, and BID Lab returns. The series was not indicated and the valuation was not disclosed.

Sofía operates under a licence as a specialised health insurance institution and reinsures with Reinsurance Group of America (RGA) (Periodismo y Ambiente). It sells companies a no-deductible policy with its own medical network of more than 2,000 specialists and 400 hospitals and clinics. It had more than 1,300 corporate clients, among them Rappi, Clara and Reina Madre, renewal above 95% and an NPS of 75. Proceeds will fund growth, artificial intelligence in operations and clinical support, and new prevention and everyday care products. It is run by Arturo Sánchez Correa, co-founder and chief executive.

Value drivers

Licence and reinsurance. Sofía retains risk as a specialised health insurance institution and cedes part of it to RGA. In our reading, this separates it from an enabler or a digital broker: regulatory capital, a global reinsurer validating its underwriting, and a barrier to entry that software does not provide.

Renewal as the asset. Renewal above 95% and an NPS of 75 across 1,300 companies (Sofía). In group insurance, the renewed book is the cash flow an investment committee capitalises; in our reading, it is the metric that held the price of this round.

An underserved market. Only one in ten people in Mexico has private health insurance and 7% of companies offer it as a benefit (Periodismo y Ambiente). SMEs are the segment traditional insurers reach least.

A returning syndicate and a new name. That the previous lead leads again, with Index and Kaszek inside and a new fund setting the price, indicates in our reading a continuity round with external validation. Life and health captured 76% of regional insurtech funding in the first half of 2026 (MAPFRE); in March Kfund co-led the Series A of Bliss in Brazil on the same thesis.

What the market is signalling

In Mexico, insurtech capital over the last twelve months went to models with a licence or with an incumbent insurer behind them: Momento Seguros, a digital motor insurer, raised USD 10 million in September 2025 co-led by Hedosophia and American Family Ventures, and GNP invested MXN 137 million in Meddi in March 2026 as a strategic minority investor. Sofía is the direct comparable for any Mexican digital insurer seeking capital: licence, reinsurance, own network and documented retention.

For traditional major medical insurers, competition for SMEs arrives with a no-deductible product and capital to acquire customers. For lenders, the lesson is the usual one in insurance: debt does not substitute for regulatory capital, and a licensed insurer is capitalised with equity and reinsurance. For Mexican health founders, the licensed route is longer and more expensive than that of a digital broker, but it is the one that draws global funds into successive rounds.

G2’s reading for a mandate

A round for a licensed insurer demands a different book from that of a software insurtech: regulatory filings with the CNSF showing the solvency capital requirement and its coverage, loss experience by cohort, the reinsurance treaty with its cession terms, unit economics per insured member and the renewal calendar for the following twelve months. The competitive process opens with the existing lead already aligned and a new fund invited to set the price; the valuation is defended with the renewed book, not with the technology.

Sources

More analyses in this sector